Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-12-24Clinical Trial Update: Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia [Phase 2]
Phase 2 clinical trial evaluating vaccination in the peripheral stem cell transplant setting for acute myeloid leukemia has completed. Spons…
-
CLINICAL_TRIALS trial_result · 2007-11-02Clinical Trial Update: Pulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old Children
Completed clinical trial investigating pulmonary function at presentation and during follow-up in children aged 3-7 years with hematologic c…
-
CLINICAL_TRIALS trial_result · 2007-07-17Clinical Trial Update: AML96 - Risk-Adapted and Randomized Postremission-Therapy for Adult Acute Myeloid Leukemia Patients [Phase 4]
This document reports the completion of the Phase 4 AML96 trial assessing risk-adapted postremission therapy for adult acute myeloid leukemi…
-
CLINICAL_TRIALS trial_result · 2007-05-30Clinical Trial Update: Lomustine and Intermediate Dose Cytarabine in Older Patients With AML [Phase 3]
Phase 3 trial evaluating lomustine plus intermediate-dose cytarabine in older adults with Acute Myeloid Leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2007-05-15Clinical Trial Update: Study to Determine the Optimal Biologic Dose of CC-401 in Subjects With High-Risk Myeloid Leukemia [Phase 1]
Phase 1 study to determine the optimal biologic dose of CC-401 in high-risk myeloid leukemia has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-04-24Clinical Trial Update: Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization. [Phase 1]
Phase 1 safety trial evaluating parathyroid hormone for stem cell mobilization in patients with lymphoma, multiple myeloma, or acute myeloid…
-
CLINICAL_TRIALS trial_result · 2007-04-12Clinical Trial Update: Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers [Phase 1, Phase 2]
Completed Phase 1/2 clinical trial assessing infusion of ex vivo treated umbilical cord blood stem cells following chemoradiation in patient…
-
CLINICAL_TRIALS trial_result · 2007-03-15Clinical Trial Update: Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care
The study evaluating Mylotarg (gemtuzumab ozogamicin) in usual care for acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2007-02-19Clinical Trial Update: Amonafide in Combination With Cytarabine in Secondary AML [Phase 2]
A Phase 2 trial evaluating amonafide in combination with cytarabine for secondary acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2006-11-14Clinical Trial Update: Voriconazole or Placebo in the Prophylaxis of Lung Infiltrates in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia [Phase 3]
A Phase 3 trial evaluating voriconazole prophylaxis versus placebo in patients with acute myeloid leukemia undergoing induction chemotherapy…
-
CLINICAL_TRIALS trial_result · 2006-10-26Clinical Trial Update: L-Ascorbic Acid Depletion to Treat Acute Myeloid Leukemia and Myelodysplastic Syndromes [Phase 2]
Phase 2 clinical trial of L-ascorbic acid depletion to treat acute myeloid leukemia and myelodysplastic syndromes is currently suspended.
-
CLINICAL_TRIALS trial_result · 2006-10-13Clinical Trial Update: A Randomized Trial of Human Growth Hormone (hGH) vs Placebo in Intensively Treated Haemato-Oncology Patients. [Phase 2, Phase 3]
The document provides an update on a randomized trial comparing somatropin (human growth hormone) to placebo in intensively treated hematolo…
-
CLINICAL_TRIALS trial_result · 2006-05-18Clinical Trial Update: Study Evaluating Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia After Stem Cell Transplant [Phase 2]
A Phase 2 study evaluating gemtuzumab ozogamicin in acute myeloid leukemia patients after stem cell transplant has completed.